TENX
TENAX THERAPEUTICS, INC.
Latest Form 4:Purchase$360KbyADAR1 Capital Management, LLC (10% Owner) · filed Aug 24, 2026
TENAX THERAPEUTICS, INC. (TENX) has 9 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 24, 2026.
The most active filer is Chief Medical Officer Rich Stuart with 5 filings. Insiders have net bought $1.8M over the trailing 6 months. The largest single insider purchase in this window was $1.3M by 10% Owner ADAR1 Capital Management, LLC on Aug 21, 2026.
- Industry:Biotechnology
- CEO:Christopher T. Giordano
- Employees:16
- HQ:Chapel Hill, NC, US
- IPO:1994-04-04
Insider Buying
$2.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$69.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 202,124 | $360K | Aug 24 | SEC ↗ | |
| 10% Owner | Purchase | 716,369 | $1.3M | Aug 24 | SEC ↗ | |
| 10% Owner | Purchase | 107,374 | $188K | Aug 24 | SEC ↗ | |
| Chief Medical Officer | Purchase | 2,500 | $25K | Dec 10 | SEC ↗ | |
| Chief Medical Officer | Purchase | 2,500 | $26K | Dec 10 | SEC ↗ | |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 1,000 | $9K | Dec 5 | SEC ↗ |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 1,500 | $14K | Dec 5 | SEC ↗ |
Rich StuartFirst filing | Chief Medical Officer | Purchase | 2,500 | $23K | Dec 5 | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 1,612 | $13K | Nov 20 | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 455 | $3K | Nov 20 | SEC ↗ |
Giordano Christopher ThomasFirst filing | CEO | Purchase | 538 | $4K | Nov 20 | SEC ↗ |
| Director | Purchase | 93 | $665 | Nov 20 | SEC ↗ | |
| Director | Purchase | 1,900 | $14K | Nov 20 | SEC ↗ | |
MCGAULEY THOMASFirst filing | Interim CFO | Purchase | 8,000 | $58K | Nov 19 | SEC ↗ |
Related companies
TENAX THERAPEUTICS, INC. is in the Healthcare sector.